Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMICADE in Patients With Asthma Receiving Inhaled Corticosteroids
NCT00278083Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Oct 2001
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of infliximab in asthma, sponsored by Imperial College London. Started Oct 2001; status: completed.
02
Drugs
infliximab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00278083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278083.